Quarterly report pursuant to Section 13 or 15(d)

Stock-based compensation (Tables)

v2.4.0.8
Stock-based compensation (Tables)
 9 Months Ended
Sep. 30, 2014
Tecogen
  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity
Stock option activity for the nine months ended September 30, 2014 was as follows: 
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2013
1,148,000

 
 $1.20-$4.50

 
$
2.13

 
5.80 years

 
$
2,721,100

Granted
118,325

 
$4.50-$5.39

 
4.69

 
—

 
—

Exercised
(5,000
)
 
1.20

 
1.20

 
—

 
—

Canceled and forfeited
(7,000
)
 
 $1.20-$4.50

 
3.32

 
—

 
—

Expired
—

 
—

 
—

 
—

 
—

Outstanding, September 30, 2014
1,254,325

 
 $1.20-$5.39

 
$
2.37

 
5.49 years

 
$
7,051,694

Exercisable, September 30, 2014
929,250

 
 
 
$
1.92

 
 
 
$
5,638,158

Vested and expected to vest, September 30, 2014
1,254,325

 
 
 
$
2.37

 
 

 
$
7,051,694

Schedule of Restricted Stock Activity
Restricted stock activity for the nine months ended September 30, 2014 as follows:
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2013
361,570

 
$
1.31

Granted
—

 
—

Vested
—

 
—

Forfeited
—

 
—

Unvested, September 30, 2014
361,570

 
$
1.31

Ilois
  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity
Stock option activity relating to Ilios for the nine months ended September 30, 2014 was as follows:
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2013
575,000

 
$0.10-$0.50

 
$
0.29

 
6.44 years
 
$
120,000

Granted
50,000

 
0.50

 
0.50

 
 
 
 
Exercised
—

 
—

 
—

 
 
 
 
Canceled and forfeited
—

 
—

 
—

 
 
 
 
Expired
—

 
—

 
—

 
 
 
 
Outstanding, September 30, 2014
625,000

 
$0.10-$0.50

 
$
0.31

 
6.25 years
 
$
120,000

Exercisable, September 30, 2014
181,250

 
 

 
$
0.50

 
 
 
$
—

Vested and expected to vest, September 30, 2014
625,000

 
 

 
$
0.31

 
 
 
$
120,000

Schedule of Restricted Stock Activity
Restricted stock activity for the Ilios awards, for the nine months ended September 30, 2014 was as follows:
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2013
310,000

 
$
0.10

Granted
—

 
—

Vested
—

 
—

Forfeited
—

 
—

Unvested, September 30, 2014
310,000

 
$
0.10


Consolidated stock-based compensation expense for the nine months ended September 30, 2014 and 2013 was $120,972 and a benefit of $8,105, respectively. At September 30, 2014, the total compensation cost related to unvested restricted stock awards and stock option awards not yet recognized is $147,125. This amount will be recognized over a weighted average period of 1.14 years. No tax benefit was recognized related to the stock-based compensation recorded during the periods.